asthma
Conditions
Interventions
Sponsors
Huashan Hospital Affiliated to Fudan University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18-75 years old at the time of enrollment; 2. Patients with bronchial asthma diagnosed by modern medicine, regular inhaled hormone therapy or other conventional treatment 3 months later, patients with bronchial asthma ACT score <20 points; 3. Patients with abnormal mucus type identified by Uighur medicine; 4. Patients without upper and lower respiratory tract infections and not taking oral and intravenous glucocorticoid therapy within 2 weeks; 5. Subjects voluntarily participated in the study and signed Informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients in acute attack stage, who need oral and intravenous glucocorticoid therapy; 2. Patients with abnormal blood type, abnormal savda type, and abnormal biliary type identified by Uygur medicine; 3. Combined Patients with COPD, pulmonary fibrosis, and a history of lung resection; 4. Pregnant or planning to become pregnant or breastfeeding women; 5. Patients with malignant tumors and hematological diseases; 6. Those who have participated in clinical trials of other drugs within 3 months; 7. Those with severe impairment of heart, liver, and kidney functions (heart function grades 3 to 4, ALT and/or AST exceeding 1.5 times the upper limit of normal, and Cr exceeding the upper limit of normal); 8. Those deemed unsuitable for inclusion by the investigator Other situations.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ACT;Peak expiratory flow rate (PEF) value and average daily diurnal variation rate;Exhaled nitric oxide (FeNO); | — |
Countries
China
Contacts
Public ContactJingcheng Dong
Huashan Hospital Affiliated to Fudan University
Outcome results
None listed